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In Africa, relapsing fevers caused by ectoparasite-borne Borrelia species are transmitted
by ticks, with the exception of Borrelia recurrentis, which is a louse-borne spirochete.
These tropical diseases are responsible for mild to deadly spirochetemia. Cultured
Borrelia crocidurae, Borrelia duttonii, and Borrelia hispanica circulate alongside at least
six species that have not yet been cultured in vectors. Direct diagnosis is hindered by
the use of non-specific laboratory tools. Indeed, microscopic observation of Borrelia
spirochaeta in smears of peripheral blood taken from febrile patients lacks sensitivity and
specificity. Although best visualized using dark-field microscopy, the organisms can also
be detected using Wright–Giemsa or acridine orange stains. PCR-based detection of
specific sequences in total DNA extracted from a specimen can be used to discriminate
different relapsing fever Borreliae. In our laboratory, we developed a multiplex real-
time PCR assay for the specific detection of B. duttonii/recurrentis and B. crocidurae:
multispacer sequence typing accurately identified cultured relapsing fever borreliae and
revealed diversity among them. Other molecular typing techniques, such as multilocus
sequence analysis of tick-borne relapsing fever borreliae, showed the potential risk of
human infection in Africa. Recent efforts to culture and sequence relapsing fever borreliae
have provided new information for reassessment of the diversity of these bacteria.
Recently, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
has been reported as a means of identifying cultured borreliae and of identifying both
vectors and vectorized pathogens such as detecting relapsing fever borreliae directly in
ticks. The lack of a rapid diagnosis test restricts the management of such diseases. We
produced monoclonal antibodies against B. crocidurae in order to develop cheap assays
for the rapid detection of relapsing fever borreliae. In this paper, we review point-of-care
diagnosis and confirmatory methods.
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INTRODUCTION
In Africa, relapsing fever borreliae are neglected vector-borne pathogens responsible for var-
ious febrile presentations and are most commonly suspected in malaria-like symptoms (1).
They are ectoparasite-borne infections that are transmitted by ticks, with the exception of
Borrelia recurrentis, which is a louse-borne spirochete (1). As a result, this latter organism
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will not be considered in this review, which focuses on tick-
borne borreliae. Relapsing fevers are a concern for public health
in local populations as well as for foreigners visiting endemic
African countries. Currently, three cultured tick-borne species
(Borrelia crocidurae, Borrelia duttonii, and Borrelia hispanica) (2)
are in circulation, in addition to the as yet uncultured Borrelia
merionesi in Ornithodoros ticks in Morocco (3), Candidatus Bor-
relia algerica in febrile patients in Algeria (4) and an unnamed
new species in Ornithodoros porcinus ticks in Tanzania (5), in
the blood of Spheniscus demersus penguins in South Africa (6),
in Rhipicephalus evertsi ticks from Nigeria (7), and new Borrelia
species distinct from the Lyme disease and recurrent fever groups
detected in Amblyomma cohaerens in Ethiopia (8). B. hispanica is
prevalent in the north, B. crocidurae in the west, and B. duttonii
in the east of Africa (1, 2). However, several species of Borre-
lia may circulate in the same geographic region (3). All species
are transmitted by the bite of Ornithodoros soft ticks (9, 10).
Since relapsing fever borreliae can present with fever, they are
often misdiagnosed as malaria (11). Moreover, relapsing fever
borreliae may form part of mixed infections, further compli-
cating the diagnosis (12). A relapse within days is the clinical
hallmark of these infections, causing mild to deadly septicemia
and miscarriage in people exposed to endemic regions (1). The
clinical picture initially includes a fever over 39°C with chills
and polyalgia; it may also include vomiting, abdominal pain,
and diarrhea. Physical examination may find rash, splenomegaly,
and hepatomegaly (2). All species may cause iritis, iridocycli-
tis, uveitis, and central nervous system infection. The mortal-
ity rate is estimated to be between 2 and 5%, depending on
the causative Borrelia species, the highest mortality rate being
observed with B. recurrentis (1). The most recent epidemiologi-
cal data indicate that 43.92 million people living in rural Africa
in endemic countries and 19.17 million travelers are at risk of
relapsing fever in west and north African countries (3). The
incidence of tick-borne relapsing fever has been measured at
11% in rural Senegal (9). Due to its sudden onset, and because
the first fever attack is the most dangerous, lengthy diagnos-
tic procedures, including in vitro culturing and animal inocu-
lation, cannot be considered for routine diagnosis. Currently,
detection of relapsing fever borreliae in Africa relies upon the
observation of spirochaeta in smears of peripheral blood; how-
ever, the high morphological similarity between species does
not allow for identification at the species level. Molecular meth-
ods, detecting single nucleotide polymorphisms in the 16S rRNA
and flaB genes, 16S-23S ribosomal RNA intergenic spacer (IGS),
multispacer sequence typing (MST), multilocus sequence typing
(MLST), and multiplex quantitative real-time PCR (4, 13, 14),
may not be routinely available in most endemic regions (15).
Nevertheless, rapid diagnosis of relapsing fever is warranted,
since these cases require specific treatment and prophylaxis in
order to avoid contact with small rodents and their ticks (12).
Relapsing fevers remain undiagnosed partly due to the lack of
point-of-care (POS) diagnostic tools in endemic countries (15),
resulting from the fastidious nature of the tools and the lack of
attention from doctors andmicrobiologists toward febrile patients
returning from endemic areas. Here, we review the tools that are
currently available for the diagnosis of relapsing fever borreliae in
hosts in Africa.
RAPID DIAGNOSIS AT THE
POINT-OF-CARE
The gold-standard diagnosis for relapsing fever borreliae is direct
microscopic visualization of borreliae in a Giemsa-stained thick
blood smears (12, 16). Borreliae are best detected in blood
obtained while a patient is febrile. During subsequent febrile
episodes, the number of circulating spirochaeta decreases, making
it harder to detect them on a peripheral blood smear (16). One
study, using thick blood smears from febrile cases stained with
Giemsa and observed in 200 oil immersion fields (1000) (equiv-
alent to about 0.5L blood), determined that during the febrile
episode, the blood-borne inoculumwas 103–105 borreliae per mL
(9, 16). This figure indicates that conventional microscopic exam-
ination of a blood drop yields only one Borrelia every 10 micro-
scopic fields. Accordingly, microscopic examination of red blood
cells for Plasmodiummay easily overlook borreliae, which are free
in the plasma (17) or sticking to blood cells (Figure 1). Direct
detection either of motile spirochaeta by dark-field microscopy
or staining of borreliae by fluorescent antibody methods in such
tissues may be used (18, 19). The inability of dark-field micro-
scopic analysis to detect spirochaeta in 100 field-collected ticks (16
infected ticks) compared with PCR (22 infected ticks) (20) illus-
trated the need for more sensitive tests. To provide simple, fast,
cheap, and sensitive diagnoses using equipment that is available in
small health centers, a method based on enrichment of bacteria by
centrifugation and detection by Giemsa staining was developed,
which is capable of detecting fewer than 10 spirochaeta per mL of
blood (12, 21). PCR-based detection of specific sequences is the
modern method for POC laboratory diagnosis (15). Total DNA
is most often extracted from blood using a QIAamp DNA Micro
kit according to the manufacturer’s protocol (QIAGEN, Hilden,
Germany) (4, 22). Because of the close genetic and genomic prox-
imity of the relapsing fever borreliae, as illustrated by 16S rRNA
gene sequence variability 1%, confirmed by B. duttonii and B.
recurrentis genomics, indicating that the two organisms belonged
to the same bacterial species (22–24), molecular tests may detect
FIGURE 1 | Presence of extraerythrocytic Borrelia crocidurae (arrow)
in a blood smear from guinea pigs using dark-field microscopy.
Magnification 400.
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FIGURE 2 | Diagnosis of African relapsing fever: a review. Conventional microscopic identification (A) and molecular identification (B).
relapsing fever borreliae without providing species identification.
Observations that the glycerophosphodiester phosphodiesterase
(glpQ) gene and its antigenic protein product were present in
relapsing fever borreliae and absent in Lyme disease borreliae led
to the development of group-specific molecular and serological
tests (25). Detection of Borrelia flagellin DNA (flaB) by real-time
PCR amplification from the blood is highly sensitive and specific,
detecting as few as 10 borreliae per mL of blood (26). Real-time
PCR can be efficiently used in POC settings, as shown in rural
Senegal (15, 27). In this example, extracted blood DNA could
be stored at 4°C until used for PCR amplification. Ready-to-use
lyophilized reagents can be prepared in a core-laboratory and
shipped to rural POC facilities (15). The lyophilized mixtures can
be stored for at least 2months at 20°C without loss of activity
(Figure 2). The same approach has recently been used for the
POC molecular diagnosis of Buruli ulcers in order to facilitate
the diagnosis of Mycobacterium ulcerans infection in endemic
countries (27). While commercially available real-time PCR solu-
tions may be beyond the financial capacities of some countries,
specific financing programs are available to promote advanced
molecular diagnosis in endemic countries, as illustrated by rural
POC facilities (15).
CONFIRMATORY DIAGNOSIS IN
THE REFERENCE LABORATORY
Molecular Typing
Molecular typing confirms Borrelia and allows for fine species
identification. Several approaches, including analysis of the IGS
located between the 16S rRNA and 23S rRNAgenes, only explored
the variability between B. duttonii and B. recurrentis (28). More-
over, IGS sequences overlapped between one B. duttonii phyloge-
netic group and one B. recurrentis group, with a second overlap
being revealed upon subsequent analysis of further material (28).
In Mali, the inclusion of MLST revealed the endemic foci of tick-
borne relapsing fever borreliae and the potential risk for human
infection (14). Borrelia contains numerous linear and circular
plasmids (23, 29, 30). MLST looks for differences between plas-
mid profiles and DNA sequence data. MST looks for differences
between five IGSs in B. crocidurae, B. duttonii, and B. recurrentis
genomes. It is a suitable PCR-sequencing-based method for iden-
tifying and genotyping relapsing fever borreliae in Africa in both
vectors and clinical specimens (13). B. hispanica is responsible
for relapsing fever borreliae in Spain (31) and previous molecular
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TABLE 1 | Diagnosis of relapsing fever borreliae in travelers returning to Europe from Africa over the past 15 years.
Reference laboratory Countries of
exposure
Methods Reference
Infectious Diseases and Tropical Medicine ward in North Hospital,
Marseille, France
Senegal Microscopic
Molecular tests
(35)
The Emergency Department of American Hospital of Paris, France Mali Microscopic (37)
Clinic and Laboratory of Infectious Diseases, University of Siena,
Siena, Italy
Senegal Microscopic
Molecular tests
(36)
Biology laboratory of the Centre Hospitalier d’Argenteuil, France Senegal Microscopic
Molecular tests
(38)
Service de Médecine Interne, Groupe Hospitalier Mutualiste de
Grenoble, France
Lyme disease serodiagnostic assays
(ELISA and Western blot)
Culture
University Hospital of Antwerp, Belgium Senegal Molecular tests (39)
Université de la Méditerranée, Marseille, France
Hôtel-Dieu Hospital, Paris, France Morocco Microscopic (34)
Hôpital de Mantes in Mantes-la-Jolie, France Mali Molecular tests
Avicenne Hospital in Bobigny, France Mauritania
Service de maladies infectieuses et réanimation médicale, CHU
Pontchaillou, Rennes, France
Senegal Microscopic
Molecular tests
(40)
Infectious Diseases and Tropical Medicine ward in North Hospital,
Marseille, France
Ethiopia Molecular tests
Immunofluorescence assay
Lyme disease serodiagnostic assays (ELISA)
(41)
studies have identified this species in patients with unexplained
fever in north-western Morocco (32). However, local transmis-
sion has not been detected in Morocco since 1976 (33), with the
exception of one traveler returning from Spain and Morocco with
a B. hispanica infection (34). Although not present in Europe
or near its boundaries, other relapsing fever borreliae species
are of interest to European physicians because of the increase
in international travel and cases of European tourists import-
ing relapsing fevers. B. crocidurae has been detected in travelers
returning from Senegal (35, 36) andMali (37), and other relapsing
fever borreliae have been detected in travelers returning to Europe
from Africa over the past 15 years (Table 1). Relapsing fever
borreliae are therefore considered as emerging diseases and should
consequently be considered in all febrile patients returning from
endemic countries.
Techniques for Epidemiological Study
Molecular typing is used for species identification of Borrelia in
epidemiological studies (13, 14, 28). In Ethiopia, molecular inves-
tigation of 284 cattle ticks found a potential new Borrelia species
distinct from both the relapsing fever group and Lyme borreliae
(8). In Ethiopia, B. recurrentisDNA has also been found in 23% of
head lice from patients with louse-borne relapsing fever (42).
Xenodiagnosis
Because relapsing fever borreliae are vector-borne pathogens, it
is possible to use xenodiagnosis to detect the causative Borrelia
in the vector. We recently developed a protocol for the rapid
detection of B. crocidurae in Ornithodoros soft ticks using matrix-
assisted laser desorption/ionization time-of-flightmass spectrom-
etry (MALDI-TOF-MS) (43).MALDI-TOF-MS is, thus, emerging
as a potential tool for the rapid identification of vectors (44) and
spirochaeta such as Leptospira (45) and Borrelia (46). We first
extended it to the dual identification of vectors and vectorized
relapsing fever borreliae directly in ticks (43). For each Borrelia
species, a consensus pattern referred to as the mean spectrum
projection (MSP) was obtained using the Biotyper MSP Creation
Standard Method (Bruker Daltonics). A Borrelia MALDI-TOF-
MS database was created for relapsing fever borreliae and yielded
a unique protein profile for each species.
After the database had been developed, MALDI-TOF-MS was
able to be used to identify tick species and the presence of relapsing
fever borreliae in a single assay. The Borreliae database, along
with a custom software program that subtracts the uninfected
Ornithodoros sonrai profile, was used to detect B. crocidurae. The
legs were homogenized and the supernatant was spotted onto
a steel target plate in quadruplicate. Using in-house subtraction
software, the MSP pattern of non-infected O. sonrai was removed
from the pattern of infected ticks. This software normalizes the
spectra and compares common peaks in infected and uninfected
ticks, subsequently generating theMSP spectra before performing
the subtraction. After subtraction, the list of remaining differential
masses (m/z) was compared with the B. crociduraeMSP.
Isolation and Culture
Screening tests currently consist of microscopic examination
and culture of midgut tissues dissected from live vectors of
relapsing fever borreliae (18). Although somewhat difficult and
time-consuming, this culture is definitive for the diagnosis of
spirochaetal infections in ticks. It also provides a source of
new Borrelia strains (47). Borreliae grow at 32°C in Barbour-
Stoenner-Kelly-H (BSK-H) medium supplemented with 10%
heat-inactivated rabbit serum. Dark-field microscopic observa-
tion ensures the absence of any contaminant organisms and gages
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the growth of the borreliae. Fresh blood samples from infected
patients can be cultured using BSK-H medium or by intraperi-
toneal inoculation of 6- to 8-week-old female laboratory BALB/c
mice. Borreliae in mice are detected after 5–6 days by micro-
scopic examination of Giemsa-stained peripheral blood smears,
followed by qPCR of blood samples. Outside of Africa, it has
been demonstrated that Borrelia hermsii (new world relapsing
fever borreliae) infection in mice can be quantified by qPCR and
that this technique matched the results obtained by microscopic
examination of blood smears (48). In a study based on 100 field-
collected Ixodes ricinus ticks, dark-field microscopy, culture, and
PCR were shown to be comparable as procedures for detecting
Lyme borreliosis spirochaeta in ticks. Thirteen ticks were found
to be positive through culture in BSK-H medium, 16 ticks were
found to be infected with spirochetes by dark-field microscopy,
and 22 ticks were found to contain Borrelia burgdorferi-specific
DNAbyPCRusing a primer set based on sequences of the flagellin
gene of B. burgdorferi (20). This study showed the inability of
culture to detect spirochaeta compared to dark-field microscopic
analysis and PCR. For the culture of tick-borne relapsing fever
borreliae in Africa, B. hispanica remained uncultured in axenic
medium until 1976 (49) and B. duttonii until 1999 (50). B. cro-
cidurae, first described in musk shrew blood in Senegal in 1917
(51), was only cultured in axenic medium in 1999 (52).
Serology
No reliable specific serology exists for B. crocidurae infection.
Indeed, the detection of B. burgdorferi and B. recurrentis by
IgM enzyme-linked immunosorbent assay (ELISA) was used as
a surrogate for B. crocidurae serology since it is thought that an
appreciable cross-reacting antigen homology exists between these
species andB. crocidurae (35). The glpQgene has been proposed as
a more specific recombinant antigen for serology, distinguishing
relapsing fever borreliae from Lyme disease, but this test is not
species-specific, it cannot date the infection and is not commer-
cially available (25). It also failed to detect IgG response during
early infection in some patients infected with B. recurrentis (25,
53). Serology is of little use for diagnosis as specific antibodies
are detectable only after the first week of infection (53). Moreover,
the majority of antibodies are directed toward variable membrane
proteins (Vmps), subdivided into variable small proteins (Vsps) of
20 kDa and variable large proteins (Vlps) of 37 kDa in the genus
Borrelia (54). One disadvantage of serology in endemic areas is
antibodies that remain from earlier cleared infections may result
in false-positive results (53). Moreover, several relapsing fever
proteins are cross-reactive to Treponema spirochaeta and Lyme
group borreliae (25). No antibody has been specifically developed
for the diagnosis of African relapsing fever borreliae. Recently,
we producedmonoclonal antibodies (MAbs) against B. crocidurae
and characterized two of them with a higher titer in order to
develop cheap assays for the rapid detection of relapsing fever bor-
reliae (19). By combining both MAbs into immunofluorescence
assays, relapsing fever Borrelia and specifically B. crocidurae were
detected in ticks and blood. These antibodies could be incorpo-
rated into a dot-blot, a cheap and stable formatwhich iswell-suited
to the rapid diagnosis of relapsing fevers at the POC (15).
CONCLUSION
Relapsing fevers are common diseases in local and traveling pop-
ulations exposed to endemic countries in Africa. Nevertheless,
they remain largely undiagnosed due to a lack of routine lab-
oratory tests and clinical awareness. These fevers can be easily
detected at POC using home-made, specific real-time PCR assays
(15, 27). Fine identification can be then confirmed in a refer-
ence laboratory. Relapsing borrelioses should be incorporated to
all tropical fever syndromic laboratory kits and an ethylenedi-
aminetetraacetic acid (EDTA) blood tube, along with any ectopar-
asites that have been removed, should be collected for diagnosis
purposes.
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